PURITY: >= 98% (HPLC)
FORM: Lyophilized powder
DESCRIPTION:
Semaglutide is a synthetic peptide and long-acting GLP-1 (Glucagon-Like Peptide-1) receptor agonist with 94% sequence homology to native human GLP-1. It is engineered with amino acid substitutions and a fatty diacid side chain that enhance albumin binding and extend its biological half-life. Molecular Formula: C₁₈₇H₂₉₁N₄₅O₅₉. Supplied as a lyophilized powder, verified at ≥98% purity via HPLC. Semaglutide is widely utilized in in-vitro and preclinical laboratory research involving GLP-1 receptor signaling, glucose metabolism, insulin secretion, appetite regulation, energy balance, and metabolic disease pathways. For in-vitro laboratory research only. Not intended for human consumption or therapeutic use.
PURITY: >= 98% (HPLC)
FORM: Lyophilized powder
DESCRIPTION:
Semaglutide is a synthetic peptide and long-acting GLP-1 (Glucagon-Like Peptide-1) receptor agonist with 94% sequence homology to native human GLP-1. It is engineered with amino acid substitutions and a fatty diacid side chain that enhance albumin binding and extend its biological half-life. Molecular Formula: C₁₈₇H₂₉₁N₄₅O₅₉. Supplied as a lyophilized powder, verified at ≥98% purity via HPLC. Semaglutide is widely utilized in in-vitro and preclinical laboratory research involving GLP-1 receptor signaling, glucose metabolism, insulin secretion, appetite regulation, energy balance, and metabolic disease pathways. For in-vitro laboratory research only. Not intended for human consumption or therapeutic use.